Injectable treatment for overweight and obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an injectable medication called ASC35 to see if it is safe and tolerable for people who are overweight or obese. It may help with weight management, though it is an early-stage trial focused on safety first.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must be overweight or obese to join.
- You cannot have diabetes (type 1 or type 2).
- You cannot have a history of pancreas inflammation (pancreatitis).
- You must be in generally good health with no serious ongoing medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a once-a-day pill for adults who are overweight or have obesity and also have type 2 diabetes. The goal is to see if the medication helps with weight loss and improves blood sugar control.
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
This study tests a new injectable medication to help adults with obesity or overweight who don't have diabetes lose weight. It involves a reduced-calorie diet and exercise plan, and may offer an effective treatment option for weight management.
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
This study tests an experimental injection called UBT37034 to see if it is safe and how the body handles it. It is for people who are overweight but otherwise healthy. By joining, you could help find new ways to help with weight control—and you'll receive close monitoring and care.
This study tests a weekly injection called tirzepatide to help people with obesity lose weight. It will be done at Hospital de Clínicas in Paraguay and lasts about 12 months.
Hear when a new Chronic Weight Management trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.